ONCAlert | Upfront Therapy for mRCC
Videos
Timing of Immunotherapy Discontinuation Remains Challenging in Melanoma
7:25 PM, Tue November 19, 2019
Discussing the Potential of Novel Agents for Treatment of GIST
6:51 PM, Mon November 18, 2019
ACCC Recognizes Ethan Basch on Symptom Monitoring in Oncology
5:00 PM, Mon November 18, 2019
.jpg "The Importance of the ACCC's Focus on Compensation With Ali McBride as President")
The Importance of the ACCC's Focus on Compensation With Ali McBride as President
3:00 PM, Mon November 18, 2019
.jpg "Evaluating the Potential Role of Ibrutinib in Patients With Hairy Cell Leukemia")
Evaluating the Potential Role of Ibrutinib in Patients With Hairy Cell Leukemia
7:51 PM, Fri November 15, 2019
Mirvetuximab Soravtansine Remains Well Tolerated in Platinum-Resistant Ovarian Cancer
7:01 PM, Thu November 14, 2019
Addressing an Unmet Medical Need in Urothelial Carcinoma
6:32 PM, Wed November 13, 2019
Factors Impacting Induction Therapy Selection in AML
7:43 PM, Tue November 12, 2019
